BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Down 1.1 %

NASDAQ BIOL opened at $0.01 on Thursday. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94. The business has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.02. The stock has a market cap of $247,712.91, a PE ratio of 0.00 and a beta of 0.67.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.